All Stories

  1. Anti-glomerular basement membrane disease - treatment standard

    Article • Nephrology Dialysis Transplantation, September 2025, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  2. Advances in the treatment of ANCA-associated vasculitis

    Article • Nature Reviews Rheumatology, June 2025, Springer Science + Business Media

    Dr Stephen P McAdoo

  3. Long-Term Follow-Up of a Glucocorticoid Minimizing Regimen for the Treatment of Severe Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis

    Article • Kidney International Reports, June 2025, Elsevier

    Dr Stephen P McAdoo

  4. B-Cell Depletion in Glomerular and Autoimmune Diseases: Too Much of a Good Thing?

    Article • Kidney International Reports, May 2025, Elsevier

    Dr Stephen P McAdoo

  5. SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

    Article • Nature Reports Stem Cells, July 2023, Springer Science + Business Media

    Dr Benjamin Mullish, Dr Stephen P McAdoo

  6. International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology

    Article • Kidney International, July 2023, Elsevier

    Dr Stephen P McAdoo

  7. Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

    Article • The Lancet Regional Health - Europe, June 2023, Elsevier

    MD Pilar Rivera Ortega, Trudie Chalder, Dr Stephen P McAdoo, Prof. Markus Ralser

  8. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

    Article • The Lancet Respiratory Medicine, April 2023, Elsevier

    MD Pilar Rivera Ortega, Trudie Chalder, Dr Stephen P McAdoo, Prof. Markus Ralser

  9. Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

    Article • EClinicalMedicine, March 2023, Elsevier

    MD Pilar Rivera Ortega, Dr Cherie Armour, Dr Stephen P McAdoo, Prof. Markus Ralser

  10. Antibody prevalence after 3 or more COVID-19 vaccine doses in 23,000 immunosuppressed individuals: a cross-sectional study from MELODY

    Article • February 2023, Cold Spring Harbor Laboratory Press

    Dr Stephen P McAdoo

  11. Lack of seroresponse to SARS-CoV-2 booster vaccines given early post-transplant in patients primed pre-transplantation

    Article • Frontiers in Immunology, January 2023, Frontiers

    Dr Stephen P McAdoo

  12. Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study

    Article • The Journal of Rheumatology, January 2023, The Journal of Rheumatology

    Dr Stephen P McAdoo

  13. Editorial: The kidney in auto-immune and auto-inflammatory processes: Definitions, mechanisms, and biomarkers

    Article • Frontiers in Medicine, January 2023, Frontiers

    Dr Stephen P McAdoo

  14. Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence

    Article • Nature Communications, December 2022, Springer Science + Business Media

    Dr Stephen P McAdoo

  15. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

    Article • EBioMedicine, December 2022, Elsevier

    MD Pilar Rivera Ortega, Mark Philip Cassar, Prof. Markus Ralser, Professor Ahilanandan Dushianthan, Dr Cherie Armour, Dr Stephen P McAdoo

  16. Risk Stratification to Predict Renal Survival in Anti-GBM Disease

    Article • Journal of the American Society of Nephrology, November 2022, American Society of Nephrology

    Silke Brix, Sebastian Bate, Dr Stephen P McAdoo

  17. Syk Activation in Circulating and Tissue Innate Immune Cells in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

    Article • Arthritis & Rheumatology, November 2022, Wiley

    Dr Stephen P McAdoo

  18. Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients

    Article • EClinicalMedicine, November 2022, Elsevier

    Dr Stephen P McAdoo

  19. ANCA Associated Vasculitis Subtypes: Response [Response to Letter]

    Article • Journal of Inflammation Research, October 2022, Taylor & Francis

    Dr Stephen P McAdoo

  20. Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study

    Article • The Lancet Regional Health - Europe, October 2022, Elsevier

    Dr Stephen P McAdoo

  21. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

    Article • The Lancet Respiratory Medicine, August 2022, Elsevier

    Dr Omer Elneima, MD Pilar Rivera Ortega, Mark Philip Cassar, Prof Nicholas Hart, Prof. Markus Ralser, Trudie Chalder, Dr Cherie Armour, Dr Stephen P McAdoo

  22. Comparison of Vaccine Effectiveness Against the Omicron (B.1.1.529) Variant in Hemodialysis Patients

    Article • Kidney International Reports, June 2022, Elsevier

    Dr Stephen P McAdoo

  23. Kidney Transplant Recipients and Omicron: Outcomes, effect of vaccines and the efficacy and safety of novel treatments

    Article • May 2022, Cold Spring Harbor Laboratory Press

    Dr Stephen P McAdoo

  24. Glomerulonephritis and autoimmune vasculitis are independent of P2RX7 but may depend on alternative inflammasome pathways

    Article • The Journal of Pathology, May 2022, Wiley

    Dr Stephen P McAdoo

  25. Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients

    Article • May 2022, Cold Spring Harbor Laboratory Press

    Dr Stephen P McAdoo

  26. Multi-omics identify LRRC15 as a COVID-19 severity predictor and persistent pro-thrombotic signals in convalescence

    Article • May 2022, Cold Spring Harbor Laboratory Press

    Dr Stephen P McAdoo

  27. ANCA Associated Vasculitis Subtypes: Recent Insights and Future Perspectives

    Article • Journal of Inflammation Research, April 2022, Taylor & Francis

    Dr Stephen P McAdoo

  28. Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study

    Article • Journal of the American Society of Nephrology, March 2022, American Society of Nephrology

    Mårten Segelmark, Dr Stephen P McAdoo

  29. Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS

    Article • Nephrology Dialysis Transplantation, March 2022, Oxford University Press (OUP)

    Eleni Frangou, Dr Stephen P McAdoo

  30. Sex and Gender in Glomerular Disease

    Article • Seminars in Nephrology, March 2022, Elsevier

    Dr Stephen P McAdoo

  31. The authors reply:

    Article • Kidney International, March 2022, Elsevier

    Dr Stephen P McAdoo

  32. Inhibition of spleen tyrosine kinase decreases donor specific antibody levels in a rat model of sensitization

    Article • Scientific Reports, February 2022, Springer Science + Business Media

    Dr Stephen P McAdoo

  33. The changing role of glucocorticoids in the treatment of anti–neutrophil cytoplasmic antibody–associated vasculitis

    Article • Kidney International, February 2022, Elsevier

    Dr Stephen P McAdoo

  34. Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients

    Article • The Lancet, February 2022, Elsevier

    Dr Stephen P McAdoo

  35. Comparative immunogenicity of heterologous versus homologous 3rd SARS-CoV-2 vaccine doses in kidney transplant recipients

    Article • January 2022, Cold Spring Harbor Laboratory Press

    Dr Stephen P McAdoo

  36. Comparison of vaccine effectiveness against the Omicron (B.1.1.529) variant in patients receiving haemodialysis

    Article • January 2022, Cold Spring Harbor Laboratory Press

    Dr Stephen P McAdoo

  37. Large-vessel vasculitis

    Article • Nature Reviews Disease Primers, January 2022, Springer Science + Business Media

    Dr Stephen P McAdoo

  38. Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis

    Article • Kidney International, December 2021, Elsevier

    Dr Stephen P McAdoo

  39. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

    Article • The Lancet Respiratory Medicine, November 2021, Elsevier

    MD Pilar Rivera Ortega, Dr Omer Elneima, Prof Nicholas Hart, Prof. Markus Ralser, Trudie Chalder, Dr Stephen P McAdoo, David Baldwin

  40. ANCA Vasculitis Induction Management During the COVID-19 Pandemic

    Article • Kidney International Reports, November 2021, Elsevier

    Dr Stephen P McAdoo

  41. COVID-19 vaccination in patients with immunity-mediated kidney disease

    Article • Nature Reviews Nephrology, October 2021, Springer Science + Business Media

    Dr Stephen P McAdoo

  42. Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients

    Article • The Lancet, October 2021, Elsevier

    Dr Stephen P McAdoo

  43. Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression

    Article • Annals of the Rheumatic Diseases, October 2021, Elsevier

    Dr Stephen P McAdoo

  44. Long-term effects of Covid-19 on the kidney

    Article • QJM, September 2021, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  45. Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients

    Article • The Lancet, September 2021, Elsevier

    Dr Stephen P McAdoo

  46. Severe COVID‐19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis

    Article • Research and Practice in Thrombosis and Haemostasis, August 2021, Elsevier

    Dr Stephen P McAdoo

  47. Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID‐19: A Binational, Registry‐Based Cohort Study

    Article • Arthritis & Rheumatology, July 2021, Wiley

    Dr Stephen P McAdoo

  48. Characterisation of an enhanced preclinical model of experimental MPO‐ANCA autoimmune vasculitis

    Article • The Journal of Pathology, July 2021, Wiley

    Dr Stephen P McAdoo

  49. Comparison of humoral and cellular responses in kidney transplant recipients receiving BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines

    Article • July 2021, Cold Spring Harbor Laboratory Press

    Dr Stephen P McAdoo

  50. Comparison of immunogenicity between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in a large haemodialysis population

    Article • July 2021, Cold Spring Harbor Laboratory Press

    Dr Stephen P McAdoo

  51. Diffuse crescentic glomerulonephritis presenting with preserved renal function

    Article • Rheumatology, June 2021, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  52. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection

    Article • Kidney International, June 2021, Elsevier

    Dr Stephen P McAdoo

  53. Masked crystalline light chain tubulopathy and podocytopathy with focal segmental glomerulosclerosis: a rare MGRS‐associated renal lesion

    Article • Histopathology, May 2021, Wiley

    Dr Stephen P McAdoo

  54. Danger-associated molecular pattern molecules and the receptor for advanced glycation end products enhance ANCA-induced responses

    Article • Rheumatology, May 2021, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  55. Serologic Screening for Coronavirus Disease 2019 in Patients With Glomerular Disease

    Article • Kidney International Reports, May 2021, Elsevier

    Dr Stephen P McAdoo

  56. Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease

    Article • Frontiers in Immunology, April 2021, Frontiers

    Dr Stephen P McAdoo

  57. COVID‐19 Reinfection in a Patient Receiving Immunosuppressive Treatment for Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

    Article • Arthritis & Rheumatology, April 2021, Wiley

    Dr Stephen P McAdoo

  58. Targeting complement in ANCA-associated vasculitis: insights from ADVOCATE

    Article • Nature Reviews Nephrology, March 2021, Springer Science + Business Media

    Dr Stephen P McAdoo

  59. Resolving thromboinflammation

    Article • Blood, March 2021, American Society of Hematology

    Dr Stephen P McAdoo

  60. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death

    Article • eLife, March 2021, eLife

    Dr Stephen P McAdoo

  61. Serum chitinase-3-like 1 protein is a useful biomarker to assess disease activity in ANCA-associated vasculitis: an observational study

    Article • Arthritis Research & Therapy, March 2021, Springer Science + Business Media

    Dr Stephen P McAdoo

  62. Collagen IVα345 dysfunction in glomerular basement membrane diseases. I. Discovery of a COL4A3 variant in familial Goodpasture’s and Alport diseases

    Article • Journal of Biological Chemistry, March 2021, Elsevier

    Dr Stephen P McAdoo

  63. Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine

    Article • The Lancet, March 2021, Elsevier

    Dr Stephen P McAdoo

  64. Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study

    Article • Rheumatology, February 2021, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  65. Validation of the ANCA renal risk score in a London cohort: potential impact of treatment on prediction outcome

    Article • Kidney International, February 2021, Elsevier

    Dr Stephen P McAdoo

  66. Longevity of SARS-CoV-2 immune responses in haemodialysis patients and protection against reinfection

    Article • January 2021, Cold Spring Harbor Laboratory Press

    Dr Stephen P McAdoo

  67. SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19

    Article • Kidney Medicine, January 2021, Elsevier

    Dr Stephen P McAdoo

  68. Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era

    Article • Kidney International Reports, January 2021, Elsevier

    Dr Stephen P McAdoo

  69. Glucocorticoid-free treatment of severe ANCA-associated vasculitis

    Article • Nephrology Dialysis Transplantation, December 2020, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  70. Maintenance rituximab treatment for ANCA-associated vasculitis: to be continued?

    Article • Rheumatology, December 2020, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  71. Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening

    Article • Transplantation, November 2020, Wolters Kluwer Health

    Dr Stephen P McAdoo

  72. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death

    Article • November 2020, Cold Spring Harbor Laboratory Press

    Dr Stephen P McAdoo

  73. A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury

    Article • Cell Reports Medicine, November 2020, Elsevier

    Dr Stephen P McAdoo

  74. Detection of SARS-CoV-2 Antibodies in Kidney Transplant Recipients

    Article • Journal of the American Society of Nephrology, October 2020, American Society of Nephrology

    Dr Stephen P McAdoo

  75. Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression

    Article • Clinical Kidney Journal, October 2020, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  76. Authors' Reply

    Article • Journal of the American Society of Nephrology, September 2020, American Society of Nephrology

    Dr Stephen P McAdoo

  77. 2020 international consensus on ANCA testing beyond systemic vasculitis

    Article • Autoimmunity Reviews, September 2020, Elsevier

    Dr Stephen P McAdoo

  78. Anti–glomerular basement membrane disease during the COVID-19 pandemic

    Article • Kidney International, September 2020, Elsevier

    Dr Stephen P McAdoo

  79. Live Imaging of Monocyte Subsets in Immune Complex-Mediated Glomerulonephritis Reveals Distinct Phenotypes and Effector Functions

    Article • Journal of the American Society of Nephrology, August 2020, American Society of Nephrology

    Dr Stephen P McAdoo

  80. Oral potassium binders: increasing flexibility in times of crisis

    Article • Nephrology Dialysis Transplantation, August 2020, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  81. High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening

    Article • Journal of the American Society of Nephrology, July 2020, American Society of Nephrology

    Dr Stephen P McAdoo

  82. A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Dr Stephen P McAdoo

  83. New Therapeutic Targets in ANCA‐associated Vasculitis

    Article • Arthritis & Rheumatology, June 2020, Wiley

    Dr Stephen P McAdoo

  84. Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model

    Article • Kidney International, June 2020, Elsevier

    Dr Stephen P McAdoo

  85. A Case Series of Patients with Isolated IgG4-related Hypophysitis Treated with Rituximab

    Article • Journal of the Endocrine Society, April 2020, Endocrine Society

    Dr Stephen P McAdoo

  86. COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?

    Article • Journal of the American Society of Nephrology, April 2020, American Society of Nephrology

    Dr Stephen P McAdoo

  87. Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines

    Article • Rheumatology, March 2020, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  88. Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines—Executive summary

    Article • Rheumatology, February 2020, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  89. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, February 2020, New England Journal of Medicine (NEJM/MMS)

    Sophie Ohlsson, Dr Stephen P McAdoo

  90. Multimodal Imaging of Granulomatosis With Polyangiitis Aortitis Complicated by Severe Aortic Regurgitation and Complete Heart Block

    Article • Circulation Cardiovascular Imaging, February 2020, Wolters Kluwer Health

    Dr Stephen P McAdoo

  91. A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury During the COVID-19 Pandemic

    Article • SSRN Electronic Journal, January 2020, Elsevier

    Dr Stephen P McAdoo

  92. Membranous Glomerulonephritis With Crescents

    Article • Kidney International Reports, November 2019, Elsevier

    Dr Stephen P McAdoo

  93. Acute Iron Deprivation Reprograms Human Macrophage Metabolism and Reduces Inflammation In Vivo

    Article • Cell Reports, July 2019, Elsevier

    Dr Stephen P McAdoo

  94. IgG4-related disease in a multi-ethnic community: clinical characteristics and association with malignancy

    Article • QJM, June 2019, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  95. Comment on: A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis: reply

    Article • Rheumatology, March 2019, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  96. A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis

    Article • Rheumatology, January 2019, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  97. Anti–Glomerular Basement Membrane Disease

    Article • Rheumatic Disease Clinics of North America, November 2018, Elsevier

    Dr Stephen P McAdoo

  98. Peroxidasin—a Novel Autoantigen in Anti-GBM Disease?

    Article • Journal of the American Society of Nephrology, October 2018, American Society of Nephrology

    Dr Stephen P McAdoo

  99. A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis

    Article • Rheumatology, September 2018, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  100. Role of the Spleen Tyrosine Kinase Pathway in Driving Inflammation in IgA Nephropathy

    Article • Seminars in Nephrology, September 2018, Elsevier

    Dr Stephen P McAdoo

  101. Antiglomerular Basement Membrane Disease

    Article • Seminars in Respiratory and Critical Care Medicine, August 2018, Thieme Publishing Group

    Dr Stephen P McAdoo

  102. Primary IgA nephropathy: current challenges and future prospects

    Article • International Journal of Nephrology and Renovascular Disease, April 2018, Dove Medical Press

    Dr Stephen P McAdoo, Rose Penfold

  103. Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis

    Article • Nephrology Dialysis Transplantation, March 2018, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  104. Ofatumumab for B cell depletion in patients with systemic lupus erythematosus who are allergic to rituximab

    Article • Rheumatology, March 2018, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  105. Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis

    Article • Nephrology Dialysis Transplantation, February 2018, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  106. Deferiprone, an Iron Chelator, is Preventive and Therapeutic in Experimental Crescentic Glomerulonephritis

    Article • November 2017, Cold Spring Harbor Laboratory Press

    Dr Stephen P McAdoo

  107. Predicting Outcome in Patients with Anti-GBM Glomerulonephritis

    Article • Clinical Journal of the American Society of Nephrology, November 2017, American Society of Nephrology

    Dr Stephen P McAdoo

  108. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients

    Article • Kidney International, September 2017, Elsevier

    Dr Stephen P McAdoo, Sophie Ohlsson

  109. BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases

    Article • Nature Communications, July 2017, Springer Science + Business Media

    Dr Stephen P McAdoo

  110. Anti-Glomerular Basement Membrane Disease

    Article • Clinical Journal of the American Society of Nephrology, May 2017, American Society of Nephrology

    Dr Stephen P McAdoo

  111. Is there a role for TNFα blockade in ANCA-associated vasculitis and glomerulonephritis?

    Article • Nephrology Dialysis Transplantation, January 2017, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  112. Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond

    Article • Nephrology Dialysis Transplantation, January 2017, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  113. P06 OFATUMUMAB FOR B CELL DEPLETION THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO ARE INTOLERANT OF RITUXIMAB

    Article • Kidney International Reports, November 2016, Elsevier

    Dr Stephen P McAdoo

  114. ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap

    Article • Kidney International Reports, November 2016, Elsevier

    Dr Stephen P McAdoo

  115. Clustering of Anti-GBM Disease: Clues to an Environmental Trigger?

    Article • Clinical Journal of the American Society of Nephrology, July 2016, American Society of Nephrology

    Dr Stephen P McAdoo

  116. Ofatumumab for B cell depletion therapy in ANCA-associated vasculitis: a single-centre case series

    Article • Rheumatology, April 2016, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  117. Spleen Tyrosine Kinase: A Crucial Player and Potential Therapeutic Target in Renal Disease

    Article • January 2016, Karger Publishers

    Dr Stephen P McAdoo

  118. Renal tubular disease in the era of combination antiretroviral therapy

    Article • AIDS, September 2015, Wolters Kluwer Health

    Dr Stephen P McAdoo

  119. Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression

    Article • Kidney International, July 2015, Elsevier

    Dr Stephen P McAdoo

  120. Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis

    Article • Ophthalmology, June 2015, Elsevier

    Dr Stephen P McAdoo

  121. Immunodeficiency-associated renal Burkitt lymphoma

    Article • British Journal of Haematology, November 2014, Wiley

    Dr Stephen P McAdoo

  122. Necrotizing and crescentic glomerulonephritis presenting with preserved renal function in patients with underlying multisystem autoimmune disease: a retrospective case series

    Article • Rheumatology, November 2014, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  123. Spleen Tyrosine Kinase Inhibition Attenuates Autoantibody Production and Reverses Experimental Autoimmune GN

    Article • Journal of the American Society of Nephrology, April 2014, American Society of Nephrology

    Dr Stephen P McAdoo

  124. Should Rituximab Be Used to Prevent Relapse in Patients with ANCA-Associated Vasculitis?

    Article • Clinical Journal of the American Society of Nephrology, March 2014, American Society of Nephrology

    Dr Stephen P McAdoo

  125. SYK inhibition in experimental autoimmune vasculitis and its glomerular expression in ANCA-associated vasculitis

    Article • The Lancet, February 2014, Elsevier

    Dr Stephen P McAdoo

  126. Anti-glomerular Basement Membrane Disease

    Article • January 2014, Springer Science + Business Media

    Dr Stephen P McAdoo

  127. Experimental crescentic glomerulonephritis: a new bicongenic rat model

    Article • Disease Models & Mechanisms, August 2013, The Company of Biologists

    Dr Stephen P McAdoo

  128. L46. Novel forms of clinical vasculitis: Anti-GBM vasculitis (Goodpasture's disease)

    Article • La Presse Médicale, April 2013, Elsevier

    Dr Stephen P McAdoo

  129. Spleen tyrosine kinase (SYK) inhibition in experimental autoimmune glomerulonephritis (EAG)

    Article • La Presse Médicale, April 2013, Elsevier

    Dr Stephen P McAdoo

  130. Focal necrotizing and crescentic glomerulonephritis in patients with normal serum creatinine

    Article • La Presse Médicale, April 2013, Elsevier

    Dr Stephen P McAdoo

  131. Proteinase-3 Antineutrophil Cytoplasm Antibody Positivity in Patients Without Primary Systemic Vasculitis

    Article • JCR Journal of Clinical Rheumatology, October 2012, Wolters Kluwer Health

    Prof Alan D Salama, Dr Stephen P McAdoo

  132. Spleen Tyrosine Kinase Is Important in the Production of Proinflammatory Cytokines and Cell Proliferation in Human Mesangial Cells following Stimulation with IgA1 Isolated from IgA Nephropathy Patients

    Article • The Journal of Immunology, September 2012, The American Association of Immunologists

    Dr Stephen P McAdoo

  133. Acute renal failure in diabetes: looking beyond diabetic retinopathy

    Article • Clinical Medicine, December 2011, Royal College of Physicians

    Dr Stephen P McAdoo

  134. Measuring the quality of end of life management in patients with advanced kidney disease: results from the pan-Thames renal audit group

    Article • Nephrology Dialysis Transplantation, October 2011, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  135. Bacterial endocarditis associated with proteinase 3 anti-neutrophil cytoplasm antibody

    Article • Clinical Kidney Journal, April 2011, Oxford University Press (OUP)

    Dr Stephen P McAdoo

  136. Fostamatinib disodium

    Article • Drugs of the Future, January 2011, Prous Science

    Dr Stephen P McAdoo

  137. Disease models of rapidly progressive glomerulonephritis

    Article • Drug Discovery Today Disease Models, March 2010, Elsevier

    Dr Stephen P McAdoo